APO Research
Talk to an analyst

APO RESEARCH · REPORT

Safety Arteriovenous Fistula (AVF) Needle

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Safety Arteriovenous Fistula (AVF) Needle Market Outlook and Growth Opportunities 2026

8 January 2026200 pages

Choose your research edition.

Industry ResearchSafety Arteriovenous Fistula (AVF) Needle Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Safety Arteriovenous Fistula (AVF) Needle Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Safety Arteriovenous Fistula (AVF) Needle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Safety Arteriovenous Fistula (AVF) Needle Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Safety Arteriovenous Fistula (AVF) Needle Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Safety Arteriovenous Fistula (AVF) Needle market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Safety Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Safety Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Safety Arteriovenous Fistula (AVF) Needle is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Safety Arteriovenous Fistula (AVF) Needle market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Safety Arteriovenous Fistula (AVF) Needle market include B. Braun, Fresenius, Nipro, JMS, Kawasumi Lab, NxStage Medical, Asahi Kasei, Beldico and Farmasol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Safety Arteriovenous Fistula (AVF) Needle market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Safety Arteriovenous Fistula (AVF) Needle and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Safety Arteriovenous Fistula (AVF) Needle sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Safety Arteriovenous Fistula (AVF) Needle market size, projected growth trends, production technologies, key applications, and end-use industries.

Safety Arteriovenous Fistula (AVF) Needle Segment by Company

B. Braun

Fresenius

Nipro

JMS

Kawasumi Lab

NxStage Medical

Asahi Kasei

Beldico

Farmasol

Hemoclean

Bain Medical

Tiankang Medical

Hongda Medical

Baihe Medical

Dalian Aohua Medical Polymer Equipment

Sansin Medical

Zhejiang Kindly Medical Devices

Ningbo Tianyi Medical Appliance

Safety Arteriovenous Fistula (AVF) Needle Segment by Type

15G

16G

17G

18G

Others

Safety Arteriovenous Fistula (AVF) Needle Segment by Application

Hospital

Clinic

Dialysis Center

Safety Arteriovenous Fistula (AVF) Needle Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Safety Arteriovenous Fistula (AVF) Needle status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Safety Arteriovenous Fistula (AVF) Needle market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Safety Arteriovenous Fistula (AVF) Needle significant trends, drivers, influence factors in global and regions.

6. To analyze Safety Arteriovenous Fistula (AVF) Needle competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Safety Arteriovenous Fistula (AVF) Needle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Safety Arteriovenous Fistula (AVF) Needle and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Safety Arteriovenous Fistula (AVF) Needle.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Safety Arteriovenous Fistula (AVF) Needle market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Safety Arteriovenous Fistula (AVF) Needle industry.

Chapter 3: Detailed analysis of Safety Arteriovenous Fistula (AVF) Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Safety Arteriovenous Fistula (AVF) Needle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Safety Arteriovenous Fistula (AVF) Needle in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Safety Arteriovenous Fistula (AVF) Needle Industry Trends Table 2. Safety Arteriovenous Fistula (AVF) Needle Industry Drivers Table 3. Safety Arteriovenous Fistula (AVF) Needle Industry Opportunities and Challenges Table 4. Safety Arteriovenous Fistula (AVF) Needle Industry Restraints Table 5. Global Safety Arteriovenous Fistula (AVF) Needle Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Safety Arteriovenous Fistula (AVF) Needle Revenue Share by Company (2021-2026) Table 7. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Company (k units) & (2021-2026) Table 8. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Company (2021-2026) Table 9. Global Safety Arteriovenous Fistula (AVF) Needle Average Price (USD/unit) of Company (2021-2026) Table 10. Global Safety Arteriovenous Fistula (AVF) Needle Company Ranking, (2024-2026) & (USD Million) Table 11. Global Safety Arteriovenous Fistula (AVF) Needle Key Company Manufacturing Base & Headquarters Table 12. Global Safety Arteriovenous Fistula (AVF) Needle Company, Product Type & Application Table 13. Global Safety Arteriovenous Fistula (AVF) Needle Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Safety Arteriovenous Fistula (AVF) Needle by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 15G Table 18. Significant Companies of 16G Table 19. Significant Companies of 17G Table 20. Significant Companies of 18G Table 21. Significant Companies of Others Table 22. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Type (2021-2026) & (k units) Table 24. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Type (2027-2032) & (k units) Table 25. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Type (2021-2026) Table 26. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Type (2027-2032) Table 27. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type (2021-2026) Table 31. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Clinic Table 34. Significant Companies of Dialysis Center Table 35. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Application (2021-2026) & (k units) Table 37. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Application (2027-2032) & (k units) Table 38. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Application (2021-2026) Table 39. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Application (2027-2032) Table 40. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application (2021-2026) Table 44. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application (2027-2032) Table 45. Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region (2021-2026) & (k units) Table 47. Global Safety Arteriovenous Fistula (AVF) Needle Sales Market Share by Region (2021-2026) Table 48. Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region (2027-2032) & (k units) Table 49. Global Safety Arteriovenous Fistula (AVF) Needle Sales Market Share by Region (2027-2032) Table 50. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Region (2021-2026) Table 53. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Region (2027-2032) Table 55. Global Safety Arteriovenous Fistula (AVF) Needle Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Safety Arteriovenous Fistula (AVF) Needle Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Safety Arteriovenous Fistula (AVF) Needle Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2026) & (k units) Table 60. Global Safety Arteriovenous Fistula (AVF) Needle Sales Market Share by Country (2021-2026) Table 61. Global Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2027-2032) & (k units) Table 62. Global Safety Arteriovenous Fistula (AVF) Needle Sales Market Share by Country (2027-2032) Table 63. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Market Share by Country (2021-2026) Table 65. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Market Share by Country (2027-2032) Table 67. B. Braun Company Information Table 68. B. Braun Business Overview Table 69. B. Braun Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. B. Braun Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 71. B. Braun Recent Development Table 72. Fresenius Company Information Table 73. Fresenius Business Overview Table 74. Fresenius Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Fresenius Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 76. Fresenius Recent Development Table 77. Nipro Company Information Table 78. Nipro Business Overview Table 79. Nipro Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Nipro Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 81. Nipro Recent Development Table 82. JMS Company Information Table 83. JMS Business Overview Table 84. JMS Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. JMS Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 86. JMS Recent Development Table 87. Kawasumi Lab Company Information Table 88. Kawasumi Lab Business Overview Table 89. Kawasumi Lab Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Kawasumi Lab Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 91. Kawasumi Lab Recent Development Table 92. NxStage Medical Company Information Table 93. NxStage Medical Business Overview Table 94. NxStage Medical Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. NxStage Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 96. NxStage Medical Recent Development Table 97. Asahi Kasei Company Information Table 98. Asahi Kasei Business Overview Table 99. Asahi Kasei Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Asahi Kasei Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 101. Asahi Kasei Recent Development Table 102. Beldico Company Information Table 103. Beldico Business Overview Table 104. Beldico Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Beldico Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 106. Beldico Recent Development Table 107. Farmasol Company Information Table 108. Farmasol Business Overview Table 109. Farmasol Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Farmasol Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 111. Farmasol Recent Development Table 112. Hemoclean Company Information Table 113. Hemoclean Business Overview Table 114. Hemoclean Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Hemoclean Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 116. Hemoclean Recent Development Table 117. Bain Medical Company Information Table 118. Bain Medical Business Overview Table 119. Bain Medical Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Bain Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 121. Bain Medical Recent Development Table 122. Tiankang Medical Company Information Table 123. Tiankang Medical Business Overview Table 124. Tiankang Medical Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Tiankang Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 126. Tiankang Medical Recent Development Table 127. Hongda Medical Company Information Table 128. Hongda Medical Business Overview Table 129. Hongda Medical Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Hongda Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 131. Hongda Medical Recent Development Table 132. Baihe Medical Company Information Table 133. Baihe Medical Business Overview Table 134. Baihe Medical Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Baihe Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 136. Baihe Medical Recent Development Table 137. Dalian Aohua Medical Polymer Equipment Company Information Table 138. Dalian Aohua Medical Polymer Equipment Business Overview Table 139. Dalian Aohua Medical Polymer Equipment Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Dalian Aohua Medical Polymer Equipment Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 141. Dalian Aohua Medical Polymer Equipment Recent Development Table 142. Sansin Medical Company Information Table 143. Sansin Medical Business Overview Table 144. Sansin Medical Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Sansin Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 146. Sansin Medical Recent Development Table 147. Zhejiang Kindly Medical Devices Company Information Table 148. Zhejiang Kindly Medical Devices Business Overview Table 149. Zhejiang Kindly Medical Devices Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Zhejiang Kindly Medical Devices Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 151. Zhejiang Kindly Medical Devices Recent Development Table 152. Ningbo Tianyi Medical Appliance Company Information Table 153. Ningbo Tianyi Medical Appliance Business Overview Table 154. Ningbo Tianyi Medical Appliance Safety Arteriovenous Fistula (AVF) Needle Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Ningbo Tianyi Medical Appliance Safety Arteriovenous Fistula (AVF) Needle Product Portfolio Table 156. Ningbo Tianyi Medical Appliance Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Safety Arteriovenous Fistula (AVF) Needle Distributors List Table 160. Safety Arteriovenous Fistula (AVF) Needle Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Safety Arteriovenous Fistula (AVF) Needle Product Image Figure 2. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032) & (US$ Million) Figure 4. Global Safety Arteriovenous Fistula (AVF) Needle Sales (2021-2032) & (k units) Figure 5. Global Safety Arteriovenous Fistula (AVF) Needle Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Safety Arteriovenous Fistula (AVF) Needle Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 15G Image Figure 10. 16G Image Figure 11. 17G Image Figure 12. 18G Image Figure 13. Others Image Figure 14. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Type (2021-2032) Figure 17. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Dialysis Center Image Figure 23. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Application (2021-2032) Figure 26. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application (2021-2032) Figure 29. Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Safety Arteriovenous Fistula (AVF) Needle Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032) & (US$ Million) Figure 34. North America Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032) & (US$ Million) Figure 40. South America Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Safety Arteriovenous Fistula (AVF) Needle Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Safety Arteriovenous Fistula (AVF) Needle Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 15G
  • 16G
  • 17G
  • 18G
  • Others
Applications
  • Hospital
  • Clinic
  • Dialysis Center
Companies covered
  • B. Braun
  • Fresenius
  • Nipro
  • JMS
  • Kawasumi Lab
  • NxStage Medical
  • Asahi Kasei
  • Beldico
  • Farmasol
  • Hemoclean
  • Bain Medical
  • Tiankang Medical
  • Hongda Medical
  • Baihe Medical
  • Dalian Aohua Medical Polymer Equipment
  • Sansin Medical
  • Zhejiang Kindly Medical Devices
  • Ningbo Tianyi Medical Appliance

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032)
  4. 1.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume (2021-2032)
  5. 1.2.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Safety Arteriovenous Fistula (AVF) Needle Market Dynamics
  1. 2.1 Safety Arteriovenous Fistula (AVF) Needle Industry Trends
  2. 2.2 Safety Arteriovenous Fistula (AVF) Needle Industry Drivers
  3. 2.3 Safety Arteriovenous Fistula (AVF) Needle Industry Opportunities and Challenges
  4. 2.4 Safety Arteriovenous Fistula (AVF) Needle Industry Restraints
3 Safety Arteriovenous Fistula (AVF) Needle Market by Company
  1. 3.1 Global Safety Arteriovenous Fistula (AVF) Needle Company Revenue Ranking in 2025
  2. 3.2 Global Safety Arteriovenous Fistula (AVF) Needle Revenue by Company (2021-2026)
  3. 3.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Company (2021-2026)
  4. 3.4 Global Safety Arteriovenous Fistula (AVF) Needle Average Price by Company (2021-2026)
  5. 3.5 Global Safety Arteriovenous Fistula (AVF) Needle Company Ranking (2024-2026)
  6. 3.6 Global Safety Arteriovenous Fistula (AVF) Needle Company Manufacturing Base and Headquarters
  7. 3.7 Global Safety Arteriovenous Fistula (AVF) Needle Company Product Type and Application
  8. 3.8 Global Safety Arteriovenous Fistula (AVF) Needle Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Safety Arteriovenous Fistula (AVF) Needle Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Safety Arteriovenous Fistula (AVF) Needle Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Safety Arteriovenous Fistula (AVF) Needle Market by Type
  1. 4.1 Safety Arteriovenous Fistula (AVF) Needle Type Introduction
  2. 4.1.1 15G
  3. 4.1.2 16G
  4. 4.1.3 17G
  5. 4.1.4 18G
  6. 4.1.5 Others
  7. 4.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Type
  8. 4.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Type
  12. 4.3.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Type (2021-2032)
  14. 4.3.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type (2021-2032)
5 Safety Arteriovenous Fistula (AVF) Needle Market by Application
  1. 5.1 Safety Arteriovenous Fistula (AVF) Needle Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Dialysis Center
  5. 5.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Application
  6. 5.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Application
  10. 5.3.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Application (2021-2032)
  12. 5.3.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application (2021-2032)
6 Safety Arteriovenous Fistula (AVF) Needle Regional Sales and Value Analysis
  1. 6.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region (2021-2032)
  3. 6.2.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region: 2021-2026
  4. 6.2.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Region (2027-2032)
  5. 6.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Region (2021-2032)
  7. 6.4.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Region: 2021-2026
  8. 6.4.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Region (2027-2032)
  9. 6.5 Global Safety Arteriovenous Fistula (AVF) Needle Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032)
  12. 6.6.2 North America Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032)
  15. 6.7.2 Europe Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032)
  21. 6.9.2 South America Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Safety Arteriovenous Fistula (AVF) Needle Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Country, 2025 VS 2032
7 Safety Arteriovenous Fistula (AVF) Needle Country-level Sales and Value Analysis
  1. 7.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2032)
  4. 7.3.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2021-2026)
  5. 7.3.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales by Country (2027-2032)
  6. 7.4 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Country (2021-2032)
  7. 7.4.1 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Country (2021-2026)
  8. 7.4.2 Global Safety Arteriovenous Fistula (AVF) Needle Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Safety Arteriovenous Fistula (AVF) Needle Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Safety Arteriovenous Fistula (AVF) Needle Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 B. Braun
  2. 8.1.1 B. Braun Company Information
  3. 8.1.2 B. Braun Business Overview
  4. 8.1.3 B. Braun Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 B. Braun Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  6. 8.1.5 B. Braun Recent Developments
  7. 8.2 Fresenius
  8. 8.2.1 Fresenius Company Information
  9. 8.2.2 Fresenius Business Overview
  10. 8.2.3 Fresenius Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  12. 8.2.5 Fresenius Recent Developments
  13. 8.3 Nipro
  14. 8.3.1 Nipro Company Information
  15. 8.3.2 Nipro Business Overview
  16. 8.3.3 Nipro Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nipro Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  18. 8.3.5 Nipro Recent Developments
  19. 8.4 JMS
  20. 8.4.1 JMS Company Information
  21. 8.4.2 JMS Business Overview
  22. 8.4.3 JMS Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 JMS Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  24. 8.4.5 JMS Recent Developments
  25. 8.5 Kawasumi Lab
  26. 8.5.1 Kawasumi Lab Company Information
  27. 8.5.2 Kawasumi Lab Business Overview
  28. 8.5.3 Kawasumi Lab Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Kawasumi Lab Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  30. 8.5.5 Kawasumi Lab Recent Developments
  31. 8.6 NxStage Medical
  32. 8.6.1 NxStage Medical Company Information
  33. 8.6.2 NxStage Medical Business Overview
  34. 8.6.3 NxStage Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NxStage Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  36. 8.6.5 NxStage Medical Recent Developments
  37. 8.7 Asahi Kasei
  38. 8.7.1 Asahi Kasei Company Information
  39. 8.7.2 Asahi Kasei Business Overview
  40. 8.7.3 Asahi Kasei Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Asahi Kasei Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  42. 8.7.5 Asahi Kasei Recent Developments
  43. 8.8 Beldico
  44. 8.8.1 Beldico Company Information
  45. 8.8.2 Beldico Business Overview
  46. 8.8.3 Beldico Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beldico Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  48. 8.8.5 Beldico Recent Developments
  49. 8.9 Farmasol
  50. 8.9.1 Farmasol Company Information
  51. 8.9.2 Farmasol Business Overview
  52. 8.9.3 Farmasol Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Farmasol Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  54. 8.9.5 Farmasol Recent Developments
  55. 8.10 Hemoclean
  56. 8.10.1 Hemoclean Company Information
  57. 8.10.2 Hemoclean Business Overview
  58. 8.10.3 Hemoclean Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hemoclean Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  60. 8.10.5 Hemoclean Recent Developments
  61. 8.11 Bain Medical
  62. 8.11.1 Bain Medical Company Information
  63. 8.11.2 Bain Medical Business Overview
  64. 8.11.3 Bain Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Bain Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  66. 8.11.5 Bain Medical Recent Developments
  67. 8.12 Tiankang Medical
  68. 8.12.1 Tiankang Medical Company Information
  69. 8.12.2 Tiankang Medical Business Overview
  70. 8.12.3 Tiankang Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Tiankang Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  72. 8.12.5 Tiankang Medical Recent Developments
  73. 8.13 Hongda Medical
  74. 8.13.1 Hongda Medical Company Information
  75. 8.13.2 Hongda Medical Business Overview
  76. 8.13.3 Hongda Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hongda Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  78. 8.13.5 Hongda Medical Recent Developments
  79. 8.14 Baihe Medical
  80. 8.14.1 Baihe Medical Company Information
  81. 8.14.2 Baihe Medical Business Overview
  82. 8.14.3 Baihe Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Baihe Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  84. 8.14.5 Baihe Medical Recent Developments
  85. 8.15 Dalian Aohua Medical Polymer Equipment
  86. 8.15.1 Dalian Aohua Medical Polymer Equipment Company Information
  87. 8.15.2 Dalian Aohua Medical Polymer Equipment Business Overview
  88. 8.15.3 Dalian Aohua Medical Polymer Equipment Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Dalian Aohua Medical Polymer Equipment Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  90. 8.15.5 Dalian Aohua Medical Polymer Equipment Recent Developments
  91. 8.16 Sansin Medical
  92. 8.16.1 Sansin Medical Company Information
  93. 8.16.2 Sansin Medical Business Overview
  94. 8.16.3 Sansin Medical Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sansin Medical Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  96. 8.16.5 Sansin Medical Recent Developments
  97. 8.17 Zhejiang Kindly Medical Devices
  98. 8.17.1 Zhejiang Kindly Medical Devices Company Information
  99. 8.17.2 Zhejiang Kindly Medical Devices Business Overview
  100. 8.17.3 Zhejiang Kindly Medical Devices Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Zhejiang Kindly Medical Devices Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  102. 8.17.5 Zhejiang Kindly Medical Devices Recent Developments
  103. 8.18 Ningbo Tianyi Medical Appliance
  104. 8.18.1 Ningbo Tianyi Medical Appliance Company Information
  105. 8.18.2 Ningbo Tianyi Medical Appliance Business Overview
  106. 8.18.3 Ningbo Tianyi Medical Appliance Safety Arteriovenous Fistula (AVF) Needle Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Ningbo Tianyi Medical Appliance Safety Arteriovenous Fistula (AVF) Needle Product Portfolio
  108. 8.18.5 Ningbo Tianyi Medical Appliance Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Safety Arteriovenous Fistula (AVF) Needle Value Chain Analysis
  2. 9.1.1 Safety Arteriovenous Fistula (AVF) Needle Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Safety Arteriovenous Fistula (AVF) Needle Sales Mode & Process
  6. 9.2 Safety Arteriovenous Fistula (AVF) Needle Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Safety Arteriovenous Fistula (AVF) Needle Distributors
  9. 9.2.3 Safety Arteriovenous Fistula (AVF) Needle Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst